72.11.Z - Research and experimental development on biotechnology
10.91.Z - Manufacture of prepared feeds for farm animals
10.92.Z - Manufacture of prepared pet foods
21.10.Z - Manufacture of basic pharmaceutical substances
21.20.Z - Manufacture of medicines and other pharmaceutical products
46.46.Z - Wholesale of pharmaceutical goods
74.90.Z - Other professional, scientific and technical activities not elsewhere classified
77.40.Z - Leasing of intellectual property and similar products, except copyrighted works
85.59.B - Other out-of-school forms of education, not elsewhere classified
85.60.Z - Educational support activities
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Assets | 3,5 | 2,4 | 2,5 | 2 |
Gross profit (loss) | 0,9 | -1,1 | -0,5 | 56,1 |
EBITDA | 1,1 | -0,8 | -0,2 | 81,5 |
Net profit (loss) | 0,8 | -1,1 | -0,5 | 56,1 |
Cash | 1 | 0 | 0 | 1441,5 |
Liabilities and provisions for liabilities | 1,5 | 1,6 | 2,1 | 33,7 |
Net income from sale | 4,1 | 1,8 | 1,7 | -6,4 |
Short time liabilities | 0,2 | 0,5 | 1,2 | 148,8 |
Working assets | 2,1 | 1,1 | 1,3 | 23,6 |
Equity capital | 2 | 0,8 | 0,4 | -58 |
Operating profit (EBIT) | 0,9 | -1 | -0,4 | 64,1 |
Depreciation | 0,2 | 0,2 | 0,2 | 7,6 |
% | % | % | p.p. | |
Profitability of capital | 40,7 | -132,2 | -138,3 | -6,1 |
Equity capital to total assets | 56 | 34,6 | 14,2 | -20,4 |
Gross profit margin | 21 | -62,1 | -29,1 | 33 |
EBITDA Margin | 26,7 | -46 | -9,1 | 36,9 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 22 | 102 | 272 | 170 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane